01 5Relpax
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 6.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 382
2014 Revenue in Millions : 352
Growth (%) : -8%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 323
2015 Revenue in Millions : 352
Growth (%) : -8
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 236
2016 Revenue in Millions : 324
Growth (%) : -27
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 0
2017 Revenue in Millions : 236
Growth (%) : -100%
LOOKING FOR A SUPPLIER?